System and method for managing detrimental cardiac remodeling
First Claim
Patent Images
1. An apparatus for minimizing cardiac remodeling of a non-arrhythmic patient comprising:
- a heart stimulation device adapted to stimulate cardiac tissue, wherein the cardiac tissue comprises healthy and compromised areas;
a left ventricular electrode group, wherein the left ventricular electrode group comprises LV electrodes attached to the left ventricle at increasing distances from the AV node; and
a right ventricular electrode group, wherein the right ventricular electrode group comprises RV electrodes attached to the left ventricle at increasing distances from the AV node, andwherein, the heart stimulation device is further adapted to;
attach to the LV and RV electrodes;
generate a timing signal coincident with a refractory period; and
in response to the timing signal, send pulses to the LV and RV electrodes sequenced such that an initial pulse arrives at an LV electrode and at an RV electrode nearest the AV junction and subsequent pulses arrive at an LV and at an RV electrode progressively further from the AV junction.
1 Assignment
0 Petitions
Accused Products
Abstract
A system and method for managing and inhibiting cardiac remodeling in MI patients. Bi-ventricular stimulation is constantly provided with and without sensing to encourage normal pumping of the heart on a consistent basis. Pulses are administered using an anodal pulse followed by a cathodal pulse to stimulate cardiac muscle contraction. Stem cells are administered to MI areas to encourage regeneration of cardiac tissue in the damaged area. Stimulation may be provided to both healthy and compromised cardiac tissue.
171 Citations
17 Claims
-
1. An apparatus for minimizing cardiac remodeling of a non-arrhythmic patient comprising:
-
a heart stimulation device adapted to stimulate cardiac tissue, wherein the cardiac tissue comprises healthy and compromised areas; a left ventricular electrode group, wherein the left ventricular electrode group comprises LV electrodes attached to the left ventricle at increasing distances from the AV node; and a right ventricular electrode group, wherein the right ventricular electrode group comprises RV electrodes attached to the left ventricle at increasing distances from the AV node, and wherein, the heart stimulation device is further adapted to; attach to the LV and RV electrodes; generate a timing signal coincident with a refractory period; and in response to the timing signal, send pulses to the LV and RV electrodes sequenced such that an initial pulse arrives at an LV electrode and at an RV electrode nearest the AV junction and subsequent pulses arrive at an LV and at an RV electrode progressively further from the AV junction. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. An apparatus for minimizing cardiac remodeling of a non-arrhythmic patient comprising:
-
a heart stimulation device adapted to stimulate cardiac tissue, wherein the cardiac tissue comprises healthy and compromised areas; a left ventricular electrode group, wherein the left ventricular electrode group comprises LV electrodes attached to the left ventricle at increasing distances from the AV node; a right ventricular electrode group, wherein the right ventricular electrode group comprises RV electrodes attached to the left ventricle at increasing distances from the AV node; and a sensor, and wherein, the sensor is adapted to sense excitation of a heart chamber, and wherein, the heart stimulation device is further adapted to; attach to the LV and RV electrodes; attach to the sensor; and in response to a signal from the sensor, send pulses to the LV and RV electrodes sequenced such that an initial pulse arrives at an LV electrode and at an RV electrode nearest the AV junction and subsequent pulses arrive at an LV and at an RV electrode progressively further from the AV junction. - View Dependent Claims (8, 9, 10, 11, 12)
-
-
13. A method for minimizing cardiac remodeling of a non-arrhythmic patient comprising:
-
administering stem cells to a myocardial infarct (MI) area of a patient; continuously administering biphasic bi-ventricular stimulation to cardiac tissue outside of the MI area, wherein the biphasic stimulation comprises; a first stimulation phase having a first phase polarity, a first phase amplitude, a first phase shape, and a first phase duration, so as to precondition the myocardium to accept subsequent stimulation, and a second stimulation phase having a second phase polarity, a second phase amplitude that is larger in absolute value than the first phase amplitude, a second phase shape, and a second phase duration. - View Dependent Claims (14, 15, 16, 17)
-
Specification